Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI
· Real-Time Price · USD
14.36
-0.13 (-0.90%)
At close: Jun 27, 2025, 11:28 AM
-0.90% (1D)
| Bid | 14.36 |
| Market Cap | 2.09B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -453.94M |
| EPS (ttm) | -2.67 |
| PE Ratio (ttm) | -5.38 |
| Forward PE | -5.3 |
| Analyst | Buy |
| Ask | 14.39 |
| Volume | 490,649 |
| Avg. Volume (20D) | 1,573,891 |
| Open | 14.45 |
| Previous Close | 14.49 |
| Day's Range | 14.20 - 14.65 |
| 52-Week Range | 10.57 - 33.33 |
| Beta | 1.33 |
About DNLI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol DNLI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for DNLI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Denali Therapeutics Inc. is scheduled to release its earnings on Jul 31, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+11.8%
Denali Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
3 months ago
-8.21%
Denali Therapeutics shares are trading lower after Oppenheimer cut its price target on the stock from $50 to $42.
